Randomized controlled trial of yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma.
about
Follicular lymphoma: 2012 update on diagnosis and managementAdverse effects of biologics: a network meta-analysis and Cochrane overviewTherapeutic interventions for Burkitt lymphoma in childrenTherapeutic interventions for Burkitt's lymphoma in childrenAnti-CD45 pretargeted radioimmunotherapy using bismuth-213: high rates of complete remission and long-term survival in a mouse myeloid leukemia xenograft modelUpdate on the rational use of Y-ibritumomab tiuxetan in the treatment of follicular lymphomaSafety and efficacy of brentuximab vedotin in patients with Hodgkin lymphoma or systemic anaplastic large cell lymphomaWaldenström macroglobulinemiaFully human IgG and IgM antibodies directed against the carcinoembryonic antigen (CEA) Gold 4 epitope and designed for radioimmunotherapy (RIT) of colorectal cancersTargeted Radionuclide Therapy: Practical Applications and Future ProspectsTargeted Therapies for the Treatment of Pediatric Non-Hodgkin Lymphomas: Present and Future90 Y-ibritumomab tiuxetan: a nearly forgotten opportunityrFollicular lymphoma: 2011 update on diagnosis and managementTherapeutic radionuclides in nuclear medicine: current and future prospectsTrial Watch: Tumor-targeting monoclonal antibodies in cancer therapyToward a magic or imaginary bullet? Ligands for drug targeting to cancer cells: principles, hopes, and challengesCo-development of diagnostic vectors to support targeted therapies and theranostics: essential tools in personalized cancer therapySynthesis of peptide radiopharmaceuticals for the therapy and diagnosis of tumor diseasesComparative efficacy of 177Lu and 90Y for anti-CD20 pretargeted radioimmunotherapy in murine lymphoma xenograft modelsTheranostic applications of antibodies in oncology.The Role of Autologous and Allogeneic Stem Cell Transplantation in Follicular Lymphoma in The New Drugs EraAdvances in anticancer immunotoxin therapyRadioimmunotherapy of human tumoursAntibody-targeted radiation cancer therapyRadioimmunotherapy in Non-Hodgkin Lymphoma: Opinions of Nuclear Medicine Physicians and Radiation OncologistsPlacebo-controlled phase III trial of patient-specific immunotherapy with mitumprotimut-T and granulocyte-macrophage colony-stimulating factor after rituximab in patients with follicular lymphomaAntibody Therapies in Cancer.Antibodies as therapeutic agents: vive la renaissance!Trends in immunoconjugate and ligand-receptor based targeting development for cancer therapy.Radioimmunotherapy for NHL: experience of 90Y-ibritumomab tiuxetan in clinical practice.90Yttrium-ibritumomab tiuxetan: a novel treatment for non-Hodgkin's lymphoma.Phase I study of radioimmunotherapy with an anti-CD20 murine radioimmunoconjugate ((90)Y-ibritumomab tiuxetan) in relapsed or refractory indolent B-cell lymphoma.Ibritumomab tiuxetan for non-Hodgkin's lymphoma.Retreatment with yttrium-90 ibritumomab tiuxetan in patients with B-cell non-Hodgkin's lymphoma.Adjuvant radioimmunotherapy trial with iodine-131-labeled anti-carcinoembryonic antigen monoclonal antibody F6 F(ab')2 after resection of liver metastases from colorectal cancer.Radioimmunotherapy in relapsed follicular lymphoma previously treated by autologous bone marrow transplant: a report of eight new cases and literature review.A phase 2 study of yttrium-90 ibritumomab tiuxetan (Zevalin) in patients with chronic lymphocytic leukemia.Radioimmunotherapy with (131)I-rituximab for patients with relapsed/refractory B-cell non-Hodgkin's lymphoma (NHL).A phase I study evaluating ibritumomab tiuxetan (Zevalin®) in combination with bortezomib (Velcade®) in relapsed/refractory mantle cell and low grade B-cell non-Hodgkin lymphoma.Efficacy and safety of yttrium-90 ibritumomab tiuxetan in Japanese patients with non-Hodgkin lymphoma.
P2860
Q22252956-4D396E3A-B1F6-4DDB-8DB2-3456D1E75F17Q24234197-0570E05F-C89E-48AF-8FC8-09A3CF893F9AQ24235495-CDBFC946-58AD-4AC0-AECE-2E2C4E92FF08Q24244269-54D68D28-D85F-4FEB-97C0-0601FB510113Q24629826-F4C04EC2-871A-45F5-B3EE-901D6CFEADDDQ24633710-0D1F305F-04B6-4D21-8F12-ABF527D2DE58Q24633761-DF990BD4-7A03-4232-92C8-415675B83119Q24634076-95914703-6ECC-4985-8698-427EFE9B0E88Q24792155-50EA09F1-E12D-41F2-9884-644F0603096FQ26745926-F780DF66-7D2B-4004-A1CC-5AD27346FB0CQ26746934-9E6A89B9-6AA2-4111-BF47-7C9F710AF3A9Q26776480-AE879E8B-0E3A-4B1A-9EAA-87BB6794F2FFQ26851450-48CC109A-34B6-445E-A25F-D8FAE5F4978CQ26861998-076F3679-2607-4FD7-AAA8-C58773B2F7CAQ26993238-74DDFCFC-E4E1-4C03-B856-6E5F89B2946CQ26995399-82404CB5-C7FC-4080-AC26-5947880A23B7Q27005742-77341D3B-3E3D-4139-BF45-2546712180A4Q27025187-7642F6B9-AC87-4DD2-9FBB-712F3633D70AQ27311386-A544914E-18B3-4D14-BC56-78C0EAF33E11Q27693293-45D715BC-EDD3-4ACA-AB8E-CCD5768EDCE9Q28072397-6C6C15D1-3052-4C9B-98A8-EC0FCED394B1Q28085551-882AFA0F-F9CC-4DF8-AD0B-FE85ADB149BEQ28088825-27183711-7251-49FE-B12A-E8C2FF3656B0Q28264580-F84985F1-CE5D-46B9-BF45-D319EBABFD98Q29030891-7DCC91FC-EA7D-4361-82D9-442F67AAB185Q30419228-C13BBED7-9F69-4DC0-B700-169276673BFDQ31104000-36AE7F7D-04E0-4A35-942A-3FD380AB5F66Q33193524-D493B643-793B-4ACE-B03A-EC2259FF98B3Q33311571-EDF9EF49-35AF-4BB5-A778-462F9D4956B9Q33360887-B754D7CC-214F-43C1-9547-8F4D412D3A04Q33361773-B857717B-8EBB-4D05-AA7A-8DDEFCEE441BQ33369667-852283FF-4F92-45A4-A063-A850AB616D5DQ33371489-61386919-4B22-4CA9-A354-CC77F0C84FF4Q33376503-0F1E8D9C-7222-46CC-B4B1-DCA6D75C5EF0Q33379811-A2808F1C-12A9-4D9E-9BC7-EB4214BEA212Q33380518-EC98B389-0C80-4473-861C-8C601DBBF3C7Q33385566-BC3A9AF9-E9EB-476A-BA63-18ECF6E48FDDQ33395360-D593325A-CED7-4BFA-81F9-443B15EE78C4Q33396522-220BD4ED-F4C2-4A53-908A-50621083985CQ33402171-05E2FE23-20EF-40FA-A70D-63EFBB7190AF
P2860
Randomized controlled trial of yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Randomized controlled trial of ...... B-cell non-Hodgkin's lymphoma.
@en
Randomized controlled trial of ...... B-cell non-Hodgkin's lymphoma.
@nl
type
label
Randomized controlled trial of ...... B-cell non-Hodgkin's lymphoma.
@en
Randomized controlled trial of ...... B-cell non-Hodgkin's lymphoma.
@nl
prefLabel
Randomized controlled trial of ...... B-cell non-Hodgkin's lymphoma.
@en
Randomized controlled trial of ...... B-cell non-Hodgkin's lymphoma.
@nl
P2093
P50
P356
P1476
Randomized controlled trial of ...... B-cell non-Hodgkin's lymphoma
@en
P2093
Antonio J Grillo-López
Brad L Pohlman
Christine A White
Christos Emmanouilides
Gregory A Wiseman
Myron S Czuczman
Norman Padre
Pratik Multani
Robin Joyce
Thomas E Witzig
P304
P356
10.1200/JCO.2002.11.076
P407
P577
2002-05-01T00:00:00Z